Clinical Trial Update: Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the long-term safety and efficacy of the HSK39004 dry powder inhaler for chronic obstructive pulmonary disease, with the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• HSK39004 Dry Powder Inhaler (HSK39004)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Chronic Obstructive Lung Disease (COLD) | Phase 2 | Status: NOT_YET_RECRUITING